BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10819251)

  • 1. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
    Richter B; Berger M
    Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) [corrected].
    Richter B; Berger M
    Diabetologia; 2000 Feb; 43(2):254-8. PubMed ID: 10753051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is treatment of diabetes too complicated for general practitioners?].
    Claudi T; Cooper JG; Daae C
    Tidsskr Nor Laegeforen; 2000 Sep; 120(22):2678-82. PubMed ID: 11077516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for a reduction of myocardial infarctions by acarbose.
    van de Laar FA; Lucassen PL
    Eur Heart J; 2004 Jul; 25(13):1179; author reply 1179-80. PubMed ID: 15231377
    [No Abstract]   [Full Text] [Related]  

  • 5. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?].
    Häuser W; Ziehl S; Poltorak P; Grandt D
    Dtsch Med Wochenschr; 2005 Apr; 130(17):1069-73. PubMed ID: 15841421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type 2 diabetes: is the treatment based on evidence?].
    Boussageon R
    Rev Med Suisse; 2010 Sep; 6(260):1624-5; author reply 1625. PubMed ID: 20853719
    [No Abstract]   [Full Text] [Related]  

  • 8. [How does the PROactive Study change therapy of diabetes?].
    Erdmann E
    MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
    [No Abstract]   [Full Text] [Related]  

  • 9. The evidence for insulin lispro.
    McCormack J; Bassett K
    CMAJ; 1998 Dec; 159(11):1353-5. PubMed ID: 9861200
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment intensification in patients with type 2 diabetes.
    Barnett AH
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():iii. PubMed ID: 18435667
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive glucose lowering treatment in type 2 diabetes.
    Preiss D; Ray KK
    BMJ; 2011 Jul; 343():d4243. PubMed ID: 21791496
    [No Abstract]   [Full Text] [Related]  

  • 12. How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
    Freemantle N
    BMJ; 2005 Oct; 331(7520):836-8. PubMed ID: 16210286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical evaluation of a "therapeutic study"].
    Praxis (Bern 1994); 1997 Oct; 86(41):1603-7. PubMed ID: 9417581
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin in the diabetic heart patient, only the glycemic results count].
    Fredenrich A
    Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 16. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008).
    Drake JW
    Cleve Clin J Med; 2009 Feb; 76(2):83; author reply 83-4. PubMed ID: 19188471
    [No Abstract]   [Full Text] [Related]  

  • 18. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.